|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
65,769,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
799,253 |
Total Buy Value |
$0 |
$0 |
$0 |
$26,774,976 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
1,255,333 |
1,496,679 |
1,700,539 |
1,985,239 |
Total Sell Value |
$90,498,964 |
$108,598,573 |
$118,726,529 |
$126,687,112 |
Total People Sold |
5 |
7 |
8 |
8 |
Total Sell Transactions |
18 |
27 |
48 |
84 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Noci Darlene |
Chief Development Officer |
|
2022-10-28 |
4 |
AS |
$40.25 |
$40,250 |
D/D |
(1,000) |
0 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-10-28 |
4 |
OE |
$1.08 |
$1,080 |
D/D |
1,000 |
1,000 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-10-14 |
4 |
AS |
$21.41 |
$89,922 |
D/D |
(4,200) |
0 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-10-14 |
4 |
OE |
$1.08 |
$4,536 |
D/D |
4,200 |
4,200 |
|
- |
|
Shair Matthew |
Director |
|
2022-10-07 |
4 |
AS |
$18.69 |
$235,825 |
D/D |
(12,613) |
2,114,692 |
|
- |
|
Shair Matthew |
Director |
|
2022-10-06 |
4 |
AS |
$19.00 |
$163,552 |
D/D |
(8,608) |
2,127,305 |
|
- |
|
Shair Matthew |
Director |
|
2022-10-05 |
4 |
AS |
$19.22 |
$151,530 |
D/D |
(7,884) |
2,135,913 |
|
- |
|
Shair Matthew |
Director |
|
2022-09-15 |
4 |
AS |
$18.34 |
$103,621 |
D/D |
(5,650) |
2,143,797 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-09-15 |
4 |
AS |
$18.14 |
$76,188 |
D/D |
(4,200) |
0 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-09-15 |
4 |
OE |
$1.08 |
$4,536 |
D/D |
4,200 |
4,200 |
|
- |
|
Shair Matthew |
Director |
|
2022-09-14 |
4 |
AS |
$18.36 |
$241,452 |
D/D |
(13,151) |
2,149,447 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-08-24 |
4 |
AS |
$17.03 |
$27,316 |
D/D |
(1,604) |
0 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-08-24 |
4 |
OE |
$1.08 |
$1,732 |
D/D |
1,604 |
1,604 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-08-15 |
4 |
AS |
$17.02 |
$44,184 |
D/D |
(2,596) |
0 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-08-15 |
4 |
OE |
$1.08 |
$2,804 |
D/D |
2,596 |
2,596 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-07-19 |
4 |
AS |
$17.02 |
$5,412 |
D/D |
(318) |
0 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-07-19 |
4 |
OE |
$1.08 |
$343 |
D/D |
318 |
318 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-07-18 |
4 |
AS |
$17.07 |
$1,707 |
D/D |
(100) |
0 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-07-18 |
4 |
OE |
$1.08 |
$108 |
D/D |
100 |
100 |
|
- |
|
Shair Matthew |
Director |
|
2022-07-15 |
4 |
AS |
$18.29 |
$36,580 |
D/D |
(2,000) |
2,162,598 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-07-15 |
4 |
AS |
$17.21 |
$65,379 |
D/D |
(3,782) |
0 |
|
- |
|
Noci Darlene |
Chief Development Officer |
|
2022-07-15 |
4 |
OE |
$1.08 |
$4,085 |
D/D |
3,782 |
3,782 |
|
- |
|
Shair Matthew |
Director |
|
2022-07-13 |
4 |
AS |
$18.25 |
$1,825 |
D/D |
(100) |
2,164,598 |
|
- |
|
Noci Darlene |
See Remarks |
|
2022-07-07 |
4 |
AS |
$17.61 |
$295,848 |
D/D |
(16,800) |
0 |
|
- |
|
Noci Darlene |
See Remarks |
|
2022-07-07 |
4 |
OE |
$1.08 |
$18,144 |
D/D |
16,800 |
16,800 |
|
- |
|
158 Records found
|
|
Page 6 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|